Lipocine Inc
NASDAQ:LPCN

Watchlist Manager
Lipocine Inc Logo
Lipocine Inc
NASDAQ:LPCN
Watchlist
Price: 11.26 USD 2.36% Market Closed
Market Cap: 62.5m USD

Relative Value

The Relative Value of one LPCN stock under the Base Case scenario is hidden USD. Compared to the current market price of 11.26 USD, Lipocine Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LPCN Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
19
vs Industry
55
Median 3Y
4.2
Median 5Y
4.1
Industry
2.7
Forward
63.2
vs History
vs Industry
0
Median 3Y
-2.9
Median 5Y
-3.5
Industry
21.6
Forward
-5.5
vs History
vs Industry
Median 3Y
-3.4
Median 5Y
-5.5
Industry
16.9
vs History
vs Industry
Median 3Y
-3.2
Median 5Y
-5.1
Industry
22.9
vs History
6
vs Industry
63
Median 3Y
1
Median 5Y
1.2
Industry
2.3
vs History
7
vs Industry
64
Median 3Y
0.4
Median 5Y
0.4
Industry
3
Forward
47.5
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.6
vs History
vs Industry
51
Median 3Y
0.1
Median 5Y
-0.2
Industry
13.4
vs History
vs Industry
49
Median 3Y
0.1
Median 5Y
-0.2
Industry
16.7
Forward
-4
vs History
vs Industry
52
Median 3Y
-0
Median 5Y
-1.2
Industry
16.1
vs History
vs Industry
39
Median 3Y
-0
Median 5Y
-1.1
Industry
18.9
vs History
3
vs Industry
3
Median 3Y
2.4
Median 5Y
6.4
Industry
2

Multiples Across Competitors

LPCN Competitors Multiples
Lipocine Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Lipocine Inc
NASDAQ:LPCN
61m USD 14.1 -11.1 -7.3 -7.3
US
Eli Lilly and Co
NYSE:LLY
977B USD 16.4 53.1 35.6 38.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
528.3B USD 5.7 21 17.2 22.3
CH
Roche Holding AG
SIX:ROG
277.2B CHF 4.5 29.4 12.5 14.6
UK
AstraZeneca PLC
LSE:AZN
218.9B GBP 5 31.2 108.4 158.7
CH
Novartis AG
SIX:NOVN
222.6B CHF 4.9 19.3 12.2 15.7
US
Merck & Co Inc
NYSE:MRK
276B USD 4.3 14.5 10.3 12.2
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.4 16.5 11.5 13.3
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
147.2B USD 2.3 15 7.6 10.4
P/E Multiple
Earnings Growth PEG
US
Lipocine Inc
NASDAQ:LPCN
Average P/E: 25
Negative Multiple: -11.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
53.1
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
21
29%
0.7
CH
Roche Holding AG
SIX:ROG
29.4
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.2
37%
0.8
CH
Novartis AG
SIX:NOVN
19.3
17%
1.1
US
Merck & Co Inc
NYSE:MRK
14.5
15%
1
DK
Novo Nordisk A/S
CSE:NOVO B
16.5
3%
5.5
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
15
27%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Lipocine Inc
NASDAQ:LPCN
Average EV/EBITDA: 440
Negative Multiple: -7.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
35.6
34%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
17.2
9%
1.9
CH
Roche Holding AG
SIX:ROG
12.5
5%
2.5
UK
AstraZeneca PLC
LSE:AZN
108.4
10%
10.8
CH
Novartis AG
SIX:NOVN
12.2
6%
2
US
Merck & Co Inc
NYSE:MRK
10.3
6%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
11.5
1%
11.5
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Lipocine Inc
NASDAQ:LPCN
Average EV/EBIT: 1 883.7
Negative Multiple: -7.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.2
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
22.3
15%
1.5
CH
Roche Holding AG
SIX:ROG
14.6
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
158.7
23%
6.9
CH
Novartis AG
SIX:NOVN
15.7
12%
1.3
US
Merck & Co Inc
NYSE:MRK
12.2
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
13.3
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.4
7%
1.5